Font Size: a A A
Keyword [after Percutaneous Coronary Intervention]
Result: 81 - 100 | Page: 5 of 10
81. The Clinical Study Of The Capsule Of Rhodiola On Patients After Percutaneous Coronary Intervention
82. Evaluation Of Cardiac Function After Percutaneous Coronary Intervention Of Chronic Total Occlusion Of Coronary Artery(CTO)
83. The Study Of Health Education Program Development And Intervention For Patients After Percutaneous Coronary Intervention
84. The Correlation Between Medication Adherence And Quality Of Life After Percutaneous Coronary Intervention And Nursing Intervention
85. The Study Of T Peak-T End Interval In Coronary Heart Disease Patients Before And After Percutaneous Coronary Intervention
86. Following-up Study And Analysis Of Influencing Factors In Coronary Heart Disease Patients With Reduced Left Ventircular Ejection Fraction After Percutaneous Coronary Intervention
87. Danshen Chuanxiong Injection Clinical Studies Of Protective Effect The Contrast-induced Nephropathy Damage After Percutaneous Coronary Intervention In Patients With Blood Stasis Type Of Coronary Heart Disease
88. Behalf Of Tirofiban In Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention Study On Blood Flow And Heart Function
89. Meta-Analysis Of The Studies Assessing Short-term High-dose Statin For The Prevention Of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention
90. The Value Of Pregnancy Associated Plasma Protein A And IVS6+95Gene Polymorphism In Prediction Of Restenosis After Percutaneous Coronary Intervention
91. Prognostic Value Of Serum Total Bilirubin In Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
92. Impact Of Preoperative Single Intensive Statin On The Effect Of Myocardial Protection And MACEs In Patients With Non-ST-segment Elevation Acute Coronary Syndrome After Percutaneous Coronary Intervention
93. The Effective And Safety Of Maintenance Dose Of Clopidogrel For Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
94. Clinical Analysis And Discuss Of Clopidogrel Resistance In These Patient With Coronary Heart Disease After)Percutaneous Coronary Intervention(PCI
95. Correlation Of Plasma S1P With In-stent Retenosis After Percutaneous Coronary Intervention
96. Effects Of Congnitive-Behavioral Therapy On Anxiety,Depression And Quality Of Life And Prognosis In Patients With Coronary Heart Disease After Percutaneous Coronary Intervention Therapy
97. A Follow-up Analysis Of The Lipid Levels In Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
98. The Effects Of Tiroifban On Levels Of Interleukin-6, Von Willebrand Factor, And Soluble CD40Ligand After Percutaneous Coronary Intervention In Patients With Acute Coronary Syndrome
99. A Clinical Study On Yixin Tongmai Tang To Treat And Prevent In-stent Restenosis After Percutaneous Coronary Intervention Applied To Diabetes Mellitus With Coronary Heart Disease
100. The Change Of Concentrations Of High-sensitivity C-reactive Protein,Interleukin-18and Interleukin-10in Patients With Coronary Heart Disease Before And After Percutaneous Coronary Intervention
  <<First  <Prev  Next>  Last>>  Jump to